NMPA Approval

Mesalazine Enteric-coated Tablets

Approval Number

国药准字HJ20200007

Registration Date

April 15, 2025

Previous Approval Numbers

H20200007

Drug Information

Generic Name

美沙拉嗪肠溶片

Dosage Form

片剂

Strength

400mg

Drug Type

化学药品

Registration Date

April 15, 2025

Expiry Date

April 14, 2030

Company Address

Baslerstrasse 15, 4310 Rheinfelden, Switzerland

Company Address

Bethelner Landstrasse 18, 31028 Gronau/Leine,Germany

Empowering clinical research with data-driven insights and AI-powered tools.

美沙拉嗪肠溶片 - NMPA 批准文号 | MedPath